Amterdam Institute for Global health & Development aighd
1
Ana Cecília Gomes Rosa Luiz, Bruna Silveira Caixeta, Milena Ferreira Cruvinel et al.
1
Anaya-Covarrubias, J.Y.
1
and L.Lockerd Maragakis
1
and C. Hoffmann
1
and C. Wonodi
1
and K. Geffert
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Armocida, B.
1
Arrieta, A.
1
ARUP Laboratories
1
Asean Briefing
1
Australian Government Department of Health
1
ÄZQ
1
B. Mason Meier
1
B.S. Kamps
1
BC Centre for Disease Control
1
Beauftragte der Bundesregierung für Migration, Flüchtlinge und Integration
1
Berger, S.
1
Bhopal,S., and M. Nielsen
1
Bigoni, A.
1
BioNTech
1
BMC
1
BMC Health Services
1
Bouley, T. A.
1
Bracho C., Martinez C. et al.
1
Brazilian Journal of Health Review
1
Breathrough Action - For social and behavior change
1
British Medical Association BMA
1
British Medical Journal
1
British Society for Immunology
1
Buliva E., Elnossery S., Okwarah P. et al.
1
Bundesministerium für Migration und Flüchtlinge BAMF
1
C.
1
C. Clift
1
C. Ferreira-Borges
1
C. Victora and M. Chowdury.
1
Camp, R. and C. Hoffmann
1
Care and ONU Femmes
1
Care, ONUu Femmes et al.
1
Carolina L.A. Barbieri, C. Carvalho de Souza Amorim Matos
1
Carrillo-Larco
1
Castillo C., Villalobos Dintrans P. et al
1
Castro, A.
1
Catholic Agency for Overseas Development CAFOD
1
CDA Collaborative Learning Projects
1
Center for Operational Analysis and Research COAR
1
Center for Public Interest Communications, University of Florida
1
Centers for Disease Control and Prevention
1
Cerda A. A., Garcia L. Y.
1
Chairmen of the Committee on Doctrine and the Committee on Pro-Life Activities
1
Children for Health
1
Chimimba, F.
1
Clinical Drug Information, Inc. and its affiliates and
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Coision Nacional de Seguridad en Vacunas
1
Collective Service RCCE
1
Compass
1
Conlon C., T. McDonnell, M. Barrett, et al.
1
Conseil International des Infirmières
1
Conseil international des Infirmières (CII)
1
Corinne Grainger
1
Corona Tracker
1
Corvalan, C.
1
Couto,M.T.
1
COVID-19 Mental Disorders Collaborators
1
Cristina Aldaz, Francisco Perez
1
D. B. Evans
1
das Neves Martins Pires P.H. , Macaringue C. , Abdirazak A. et al.
1
Department of Health, Republic of South Africa
1
Desogus, A.
1
Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ)
1
Dheda, K.
1
DHS Program Demographic and Health Surveys
1
Dirección de Control de Enfermedades Inmunoprevenibles
1
Dorcas Aid International
1
Doubova SV, Leslie HH, Kruk ME, et al.
1
Dr. J. Breda
1
Dr. P. Amoth
1
Dr. S. K. Kibias
1
Dressler D. D., MD, MSc Director OF
1
Drug Safety
1
Dzabala, N. et al.
1
E. Levy Yeyati
1
E. Ross
1
E. Villalobos Prats, A. Sena et al.
1
E. Webb, M. Mckee et al.
1
Eba, B.
1
Education Santé
1
Elsevier Ltd
1
Emanuel, E.J., et al.
1
Engelman, D. et al.
1
EQUINET
1
et al
1
Ethiopian Food and Drug Authority
1
Ethiopian Food, Medicine and Healthcare Administration and Control Authority
1
EUAA European Union
1
EuroHealth Observer
1
European & Developing Countries Clinical Trials Partnership EDCTTP
1
European AIDS Clinical Society (EACS)
1
European Asylum Support Office
1
European Centers for Disease Control and Prevention ECDC
1
European Centre for disease prevention and Control
1
European Centre for Disease Prevention and Control ECDC
1
European Centre for Disease Prevention and Control (ECDC)
1
European Centre for Disease Prevention and Control ECDC, IOM
1
European Commission's Directorate-General for European Civil Protection and Humanitarian Aid Operations ECHO
1
European Observatory on Health Systems and Policies Eurostation
1
European specialist nurse organisation (ESN)
1
F. Bozzani et al.
1
F. Filippini
1
F. O. Fasina, Fasanmi O.G., Makonnen Y. J., et al.
1
F. Zerbinato Bispo Velasco, de Oliveira Pedroza, G.G. et al.
1
Federal Ministry of Health, Uganda
1
Florida International University
1
Food and Agriculture Organization of the United Nations (FAO)
1
Frase N. S.
1
GAVI Alliance
1
Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO
1
Gavi, the Vaccine Alliance
1
GBD 2019 Human Resources for Health Collaborators
1
GEF
1
German Agency for Quality in Medicine (ÄZQ)
1
Gideon
1
Global Alliance for Vaccines and Immunisation (Gavi)
1
Global Coalition for Circulatory Health
1
Global Financing Facility (GFF)
1
Global Fund
1
Global Institute for Asthma
1
Global Polio Eradication Initiative (GPEI
1
GMDAC, University of Potsdam
1
GOARN
1
Gomes Machado, F.C. et al.
1
Goodman, T.
1
Government of Burundi World Health Organization
1
Government of Malawi
1
Government of the Democratic Republic of the Congo
1
Government of the Republic of Moldova United Nations in Moldova
1
Government of the Republic of Namibia
1
Government of Uganda
1
Greinacher, A., et al.
1
Guzman-Vilca, W. C.
1
H. Adler, Gould, S.
1
Haarmann, E.
1
Haider, N.
1
Haldane, V., De Foo, C., Abdalla, S.M. et al.
1
Harding-Zentrum für Risikokompetenz
1
Hategeka C, Carter SE, Chenge FM, et al.
1
Health Care without Harm
1
Health Cluster, Nutrition Cluster, OCHA
1
Health Cluster, WHO
1
Health Sector Syria
1
Healthcare Triage
1
Heinrich-Böll Stiftung, European Union EU
1
Heliyon
1
Hine, P.
1
Hoffmann, C.
1
Holt, E.
1
Holy See Press Office
1
Honein MA, Christie A, Rose DA, et al.
1
Hopkins, D.
1
Hussein Ahmed
1
ICG
1
IFRC - International Federation of Red Cross
1
IHME Institut for Health Metrics and Evaluation
1
ILO
1
iMMAP
1
Immunization Action Coalition
1
Imperial College COVID-19 Response Team
1
Infection Prevention and Control UHL, WHO Headquarters
1
Institut de Médecine Tropicale, Université de Bordeau
1
Institute for research in international assistance
1
Inter-agency Task Force on Financing for Development
1
International Commission of Jurists
1
International Crisis Group
1
International Federation of Red Cross and Red Crescent Societies IFR
1
International Institute for Environment and Developmend (IIED)
1
International Organization for Migration (IOM)
1
International Rescue Committee
1
International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health
1
IOM Displacement Tracking Matrix - South Sudan
1
IQ-COVID Bremen
1
J. Bueno de Mesquita
1
J. Ferdosy
1
J. Kates, A. Wexler, et al.
1
J. Tjaden
1
Janković, M.
1
Jara A., Undurraga E. A. et al
1
John Hopkins Bloomberg School
1
John Hopkins University
1
Jurkovič, I.
1
Jusot, V.
1
Kalla, I.S.
1
Kelen, G.D.
1
KFF
1
Kim, A.
1
Knoll, M.D.
1
Knowledge Translation Unit
1
Kohler, S.
1
Kompetenznetz Public Health zu COVID-19
1
Kuehn, B.M.
1
Kulkarni, S.
1
Kurowski, C.
1
L. Aparecida de Souza Teles and E.G. da Silva Andrade
1
la DiCEI del Ministerio de Salud de la Nación en conjunto con la Comisión Nacional de Seguridad en Vacunas (CoNaSeVa)
1
Lalloo, U.G.
1
Lancet Oncology Commission
1
Leon-Velarde, F.
1
Lewis, C. Jr., Akinyi, M., DeWitte, S. et al.
1
Limaya, R.J.
1
Logothetis, E.
1
Logunov, D.Y, et al.
1
Louka, C.
1
M. A. Babu
1
M. Dara
1
M. M. Ahmmed
1
Machalaba
1
Machalaba, C.
1
Magalhães, C.R.
1
Malawi Human Rights Commission
1
MAMI, Irish Aid, Eleanor Crook Foundation
1
Martinez Viciana, C.
1
Mauder, S., K. Geffert
1
MEDBOX- The Aid libary
1
Medical Aid Films
1
Medicines and Healthcare products Regulatory Agency (MHRA) UK
1
Migration Policy Institute
1
Ministerio da Saude do Brasil
1
Ministerio de Salud Chile
1
Ministerio de Salud El Salvador
1
Ministerio de Salud Pública del Ecuador
1
Ministerio de Salud y Proteccion Social Bogota, Colombia
1
Ministerio de Salud, Colombia
1
Ministerio de Salud, Bogota, Colombia
1
Ministero della Salute
1
Ministère de la Santé, DR Congo
1
Ministério da Saúde Brasil
1
Ministério da Saúde, Brasil
1
Ministry of Health
1
Ministry of Health & Family Welfare ,India
1
Ministry of Health & Family Welfare Government of India
1
Ministry of Health & Family Welfare, Goverment of India
1
Ministry of Health and Family Welfare, India
1
Ministry of Health Ghana
1
Ministry of Health Rwanda, The DHS Program, et al.
1
Ministry of Health Uganda
1
Ministry of Health, Liberia, World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC)
1
Ministry of Health, South Africa
1
Misereor, Brot für die Welt, Global Policy Forum GPF
1
Mixed Migration Centre
1
Morbidity and Mortality Weekly Report MMWR
1
Mortimer, K.
1
Msomi, N.
1
Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC)
1
N.Paul, T. Bärnighausen, P. Geldsetzer
1
National Academies of Sciences, Engineering, and Medicine
1
National Centre for Disease Control
1
National Department of Health (NDoH) South Africa
1
National Department of Health South Africa
1
National Department of Health South-Africa
1
National Libary of Medicine
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...COVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19.
Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19.more
Les rassemblements sont des événements caractérisés par la con-centration de personnes dans un lieu donné, dans un but précis sur une période de temps déterminée. Le but de cette note d’orientation est de présenter la position et les orientations de l’OMS concernant la tenue de rassemb...lements pendant la pandémie de COVID-19. Elle s’adresse aux respons-ables des politiques. Les informations proviennent des publications de l’OMS et d’un examen des données probantes extraites de la littérature scientifiqumore
Updated 8 June 2021. Coronavirus is spreading globally. How can individuals, communities, humanitarian actors, local and national authorities best respond to uphold the rights of all affected people?
Workplaces outside of healthcare facilities can be also settings for transmission of COVID-19. Outbreaks of COVID-19 has been reported in various types of workplaces and job categories.
All workers should be protected from acquiring COVID-19 because of their work. The prevention of COVID-19 in ...work settings should be combined with measures for protecting physical and mental health, safety and wellbeing of workers from other occupational hazards in the operation, closures and reopening of workplaces.
This joint WHO/ILO policy brief provides a summary of the evidence for transmission of COVID-19 in general workplaces and an overview of WHO and ILO recommendations for prevention and mitigation of COVID-19 and for protecting health and safety at work in the context of the pandemic.more
This informational guide presents six strategies for immunization coordinators.
It includes tangible actions to promote confidence, communication, and uptake of COVID-19 vaccine, which can help support confidence among providers and patients.
This document is to support local authorities, leaders and policy-makers in cities and other urban settlements in identifying effective approaches and implementing recommended actions that enhance the prevention, preparedness and readiness for COVID-19 in urban settings, to ensure a robust response ...and eventual recovery. It covers factors unique to cities and urban settings, considerations in urban preparedness, key areas of focus and preparing for future emergencies.more
The global impact of COVID-19 has been profound, and the public health threat it represents is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. Here we present the results of epidemiological modelling which has informed policymaking in the UK and other countries i...n recent weeks.more
Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020.
This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level... responses to the epidemic of ‘novel coronavirus’, also known as COVID-19.more
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline... is available both online and PDF.
**This version of the living guideline (version 5.0) **includes the following seven revised statements for the prevention, identification and management of SARS-CoV-2 infections among health and care workers:
a good practice statement on national and subnational testing strategies;
a good practice statement on passive syndromic surveillance of health and care workers;
a good practice statement on prioritizing health and care workers for SARS-CoV-2 testing;
a good practice statement on protocols for reporting and managing health and care worker exposures;
a good practice statement to limit in-person work of health and care workers with active SARS-CoV-2 infections;
a statement on high-risk exposures and quarantine; and,
a conditional recommendation on the duration of isolation for health and care workers.
Understanding the updated section
Prevention of infections in the health care setting includes a multi-pronged and multi-factorial approach that includes IPC and occupational health and safety measures and adherence to Public Health and Social Measures in the community by the health workforce. The underlying infection prevention and control strategy of this section is the notion that early identification of symptomatic cases, testing and quarantining/isolating health and care workers decreases the risk of nosocomial infection to patients and to other health and care workers.more